Tandem Diabetes Care Inc
Company Profile
Business description
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Contact
12400 High Bluff Drive
San DiegoCA92130
USAT: +1 858 366-6900
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
2,650
Stocks News & Analysis
stocks
Undervalued Aussie e-commerce winner
stocks
Our view on oil prices after Maduro is deposed
stocks
Nvidia: Full steam ahead with an impressive array of announcements at CES 2026
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,018.00 | 21.50 | -0.24% |
| CAC 40 | 8,217.76 | 19.67 | -0.24% |
| DAX 40 | 25,063.12 | 170.92 | 0.69% |
| Dow JONES (US) | 49,296.62 | 165.46 | -0.33% |
| FTSE 100 | 10,047.56 | 75.17 | -0.74% |
| HKSE | 26,458.95 | 251.50 | -0.94% |
| NASDAQ | 23,586.27 | 39.10 | 0.17% |
| Nikkei 225 | 51,961.98 | 556.10 | -1.06% |
| NZX 50 Index | 13,715.02 | 51.44 | 0.38% |
| S&P 500 | 6,945.10 | 0.28 | 0.00% |
| S&P/ASX 200 | 8,695.60 | 27.90 | -0.32% |
| SSE Composite Index | 4,085.77 | 2.10 | 0.05% |